The 6 volt battery for implantable cardioverter/defibrillators

Area of Science:

• Biomedical Engineering
• Materials Science
• Electrochemistry

Background:

• Implantable defibrillators/cardioverters (ICDs) require reliable, long-lasting energy sources.
• Capacitor loading time is a critical parameter affecting device performance and patient safety.
• Existing battery technologies may present limitations in power delivery and longevity.

Purpose of the Study:

• To evaluate a novel 6 V lithium manganese dioxide battery for use in implantable defibrillators/cardioverters.
• To assess the impact of a new cathode formulation on battery performance, including ERI indication.
• To determine if the battery meets the stringent requirements for implantable medical devices.

Main Methods:

• Development of a new cathode formulation for the lithium manganese dioxide battery.
• Testing of the 6 V battery's performance characteristics, including capacitor loading time, voltage delay, and self-discharge rate.
• Evaluation of the battery's suitability as an energy source for implantable devices.

Main Results:

• The 6 V lithium manganese dioxide battery significantly reduced capacitor loading time.
• The new cathode formulation enabled ERI (Electrolyte Reserve Indication) indication.
• The battery demonstrated no voltage delays and a low self-discharge rate.
• The battery met all essential requirements for an implantable device energy source.

Conclusions:

• The 6 V lithium manganese dioxide battery is a viable and improved energy source for implantable defibrillators/cardioverters.
• The developed battery technology enhances device performance by reducing charging times and providing reliable power.
• This battery innovation addresses key needs for advanced implantable medical devices.